Chi Sheng Pharma & Biotech Co (ROCO:4111) ROCE % : 17.41% (As of Dec. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Chi Sheng Pharma & Biotech Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Chi Sheng Pharma & Biotech Co's annualized ROCE % for the quarter that ended in Dec. 2024 was 17.41%.

Chi Sheng Pharma & Biotech Co ROCE % Historical Data

The historical data trend for Chi Sheng Pharma & Biotech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chi Sheng Pharma & Biotech Co ROCE % Chart

Chi Sheng Pharma & Biotech Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

6.82

11.04

12.94

6.74

10.36

Chi Sheng Pharma & Biotech Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															3.66	8.63	7.96	7.78	17.41

Chi Sheng Pharma & Biotech Co ROCE % Calculation

Chi Sheng Pharma & Biotech Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	139.442	/	( ( (1766.103 - 451.456)	+	(1749.63 - 372.801) )	/ 2 )
	=	139.442	/	( (1314.647	+	1376.829)	/ 2 )
	=	139.442	/	1345.738
	=	10.36 %

Chi Sheng Pharma & Biotech Co's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	235.384	/	( ( (1711.73 - 383.888)	+	(1749.63 - 372.801) )	/ 2 )
	=	235.384	/	( ( 1327.842	+	1376.829 )	/ 2 )
	=	235.384	/	1352.3355
	=	17.41 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Chi Sheng Pharma & Biotech Co (ROCO:4111) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Chi Sheng Pharma & Biotech Co ROCE % Related Terms

Thank you for viewing the detailed overview of Chi Sheng Pharma & Biotech Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Chi Sheng Pharma & Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Shijian Road, Hsin Chu Industrial Park, Hsinchu County, Hukou, TWN, 30316

Website

http://www.cscp.com.tw

Chi Sheng Pharma & Biotech Co Ltd manufactures and distributes medical medicines and equipment in Taiwan. It offers injections, including hemodialysis solutions, amino acid injections, vitamin injections, and externally applied medicines.

Chi Sheng Pharma & Biotech Co Headlines

No Headlines